
NuVasive NUVA
Quarterly report 2023-Q2
added 08-02-2023
NuVasive P/S Ratio 2011-2026 | NUVA
Annual P/S Ratio NuVasive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.91 | 2.36 | 2.63 | 3.5 | 2.27 | 2.47 | 3.62 | 2.77 | 2.84 | 2.47 | 1.21 | 1.17 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 3.62 | 1.17 | 2.43 |
P/S Ratio of other stocks in the Medical devices industry
| Issuer | P/S Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
BioSig Technologies
BSGM
|
183 | - | 37.08 % | $ 85.7 M | ||
|
GenMark Diagnostics, Inc.
GNMK
|
5.44 | - | - | $ 1.77 B | ||
|
Axonics Modulation Technologies
AXNX
|
10.3 | - | - | $ 3.31 B | ||
|
Lianluo Smart Limited
LLIT
|
409 | - | 24.59 % | $ 44.8 M | ||
|
Dynatronics Corporation
DYNT
|
0.0712 | - | 14.99 % | $ 929 K | ||
|
Aziyo Biologics
AZYO
|
1.09 | - | 1.37 % | $ 20.5 M | ||
|
Acutus Medical
AFIB
|
0.731 | - | -26.83 % | $ 2.62 M | ||
|
Allied Healthcare Products
AHPI
|
0.667 | - | 3.58 % | $ 2.21 M | ||
|
Align Technology
ALGN
|
3.48 | $ 164.43 | -7.28 % | $ 12.3 B | ||
|
Obalon Therapeutics, Inc.
OBLN
|
22 | - | -5.86 % | $ 30.6 M | ||
|
Alphatec Holdings
ATEC
|
2.7 | $ 10.89 | -5.47 % | $ 1.63 B | ||
|
Conformis
CFMS
|
0.204 | - | - | $ 16.4 M | ||
|
Accuray Incorporated
ARAY
|
0.35 | $ 0.39 | 3.7 % | $ 40.1 M | ||
|
Abbott Laboratories
ABT
|
4.41 | $ 104.87 | 0.27 % | $ 183 B | ||
|
Cardiovascular Systems
CSII
|
2.49 | - | 0.15 % | $ 844 M | ||
|
Bruker Corporation
BRKR
|
0.000002 | $ 34.01 | -3.76 % | $ 5.07 K | ||
|
Second Sight Medical Products
EYES
|
44.4 K | - | -0.97 % | $ 54.4 M | ||
|
Apollo Endosurgery
APEN
|
5.24 | - | - | $ 475 M | ||
|
Boston Scientific Corporation
BSX
|
5.63 | $ 69.38 | -1.13 % | $ 103 B | ||
|
ClearPoint Neuro
CLPT
|
8.55 | $ 9.21 | -1.9 % | $ 261 M | ||
|
Avinger
AVGR
|
0.339 | - | -20.74 % | $ 369 K | ||
|
CryoLife, Inc.
CRY
|
3.58 | - | -4.14 % | $ 702 M | ||
|
CHF Solutions, Inc.
CHFS
|
0.19 | - | 1.15 % | $ 34.5 M | ||
|
Electromed
ELMD
|
2.73 | $ 24.68 | 0.93 % | $ 209 M | ||
|
CONMED Corporation
CNMD
|
0.959 | $ 35.31 | -3.64 % | $ 1.1 B | ||
|
Establishment Labs Holdings
ESTA
|
11 | $ 56.44 | -5.79 % | $ 1.67 B | ||
|
Hancock Jaffe Laboratories, Inc.
HJLI
|
1.88 K | - | -1.98 % | $ 98.3 M | ||
|
FONAR Corporation
FONR
|
0.873 | $ 18.56 | 0.11 % | $ 122 M | ||
|
Itamar Medical Ltd.
ITMR
|
8.25 | - | 0.03 % | $ 1.58 B | ||
|
NanoVibronix
NAOV
|
0.36 | - | - | $ 1.08 M | ||
|
Misonix, Inc.
MSON
|
2.96 | - | - | $ 462 M | ||
|
Neovasc
NVCN
|
266 | - | - | $ 111 M | ||
|
Helius Medical Technologies
HSDT
|
5.5 | $ 1.93 | -4.0 % | $ 1.17 M | ||
|
Intersect ENT, Inc.
XENT
|
9.12 | - | - | $ 955 M | ||
|
Integra LifeSciences Holdings Corporation
IART
|
1.17 | $ 9.24 | -1.49 % | $ 712 M | ||
|
Cytosorbents Corporation
CTSO
|
1.53 | $ 0.61 | 1.65 % | $ 33.2 M | ||
|
Aethlon Medical
AEMD
|
1.5 | $ 2.19 | -3.74 % | $ 3.42 M | ||
|
Edwards Lifesciences Corporation
EW
|
8.05 | $ 79.34 | -3.36 % | $ 46.4 B | ||
|
BIOLASE
BIOL
|
0.0039 | - | -13.19 % | $ 166 K | ||
|
Inogen
INGN
|
0.459 | $ 6.29 | -3.31 % | $ 167 M | ||
|
AdaptHealth Corp.
AHCO
|
0.371 | $ 11.13 | -2.45 % | $ 1.5 B | ||
|
LivaNova PLC
LIVN
|
2.74 | $ 61.38 | -3.57 % | $ 3.35 B | ||
|
Medtronic PLC
MDT
|
3.31 | $ 87.08 | 0.14 % | $ 112 B | ||
|
MiMedx Group
MDXG
|
1.86 | $ 3.92 | -0.51 % | $ 579 M | ||
|
OrthoPediatrics Corp.
KIDS
|
1.85 | $ 15.81 | -3.33 % | $ 371 M | ||
|
Nano-X Imaging Ltd.
NNOX
|
0.42 | $ 2.19 | -3.52 % | $ 128 M | ||
|
InspireMD
NSPR
|
12.8 | $ 1.6 | -7.51 % | $ 103 M | ||
|
Invacare Corporation
IVC
|
0.133 | - | - | $ 24.7 M | ||
|
Ra Medical Systems
RMED
|
106 | - | 10.0 % | $ 610 K |